Redefining functional MYCN gene signatures in neuroblastoma.

about

Chemoresistance, cancer stem cells, and miRNA influences: the case for neuroblastoma

P2860

Q26800007-CD707996-72C8-4250-B4EC-55276C0D7DF2

P2860

Redefining functional MYCN gene signatures in neuroblastoma.

Item

http://www.wikidata.org/entity/Q36436759

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Redefining functional MYCN gene signatures in neuroblastoma.

@ast

Redefining functional MYCN gene signatures in neuroblastoma.

@en

type

Item

label

Redefining functional MYCN gene signatures in neuroblastoma.

@ast

Redefining functional MYCN gene signatures in neuroblastoma.

@en

prefLabel

Redefining functional MYCN gene signatures in neuroblastoma.

@ast

Redefining functional MYCN gene signatures in neuroblastoma.

@en

P1476

Redefining functional MYCN gene signatures in neuroblastoma.

@en

P2093

Jason Matthew Shohet

http://www.w3.org/2001/XMLSchema#string

P2860

SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability

N-myc and noncoding RNAs in neuroblastoma

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature.

Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers.

The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.

A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma.

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study.

A review of DNA microarray analysis of human neuroblastomas.

Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification.

P304

19041-19042

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1217598109

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233385222

http://www.w3.org/2001/XMLSchema#string

P698

23139408

http://www.w3.org/2001/XMLSchema#string

P932

3511077

http://www.w3.org/2001/XMLSchema#string

Redefining functional MYCN gene signatures in neuroblastoma.

about

P2860

P2860

Redefining functional MYCN gene signatures in neuroblastoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932